Dementia
Results, Increased incidence of MCI and AD in vaccinated individuals, particularly those receiving mRNA vaccines, within three months postvaccination. mRNA vaccine group AD, Odds Ratio: 1. 225 p 0. 026 MCI, Odds Ratio: 2. 377 p less than 0. 001 No significant relationship was found with vascular dementia or Parkinson s disease. October 2022, Biden receives new COVID19 booster A potential association between COVID19 vaccination and development of Alzheimers disease 28 May 2024 Background Concerns about vaccine side effects, particularly potential links to neurodegenerative diseases such as Alzheimer s disease (AD). Aim This study investigates the association between COVID19 vaccination and the onset of AD, and its prodromal state
|
|